Consistently, the expression of phosphorylated Smad3 was higher in the SMC4-overexpressing glioma tissues and lower in the SMC4-silenced tissues compared with control tumor tissues, respectively (Figure 6g), which further support the notion that SMC4 contributes to activation of TGFβ/Smad signaling. The gene discussed is SMAD3; the disease is neoplasm.